Vanta Bioscience has entered into an exclusive agreement with Hongkong Thinkway, Hong Kong to expand its business in the pre-clinical service sector in Greater China. The company has also entered into non-exclusive agreements to cover the markets of Latin America and Asia Pacific for Chemicals and Agro-chemical business.
These are lucrative markets and the Company expects over 25% at its revenues this year to come from this initiative.
Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 482.50 |
| Indegene | 542.65 |
| CMS Info Systems | 293.55 |
| JITF Infralogistics | 314.00 |
| Sagility | 45.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: